狠狠撸

狠狠撸Share a Scribd company logo
ALZHEIMER’S
DISEASE
Yash Tripathi
BMLS Sec B
230612032159
DEFINITION:
Alzheimer’s disease (AD) is a neurodegenerative disorder, characterized by
cognitive & behavioural impairment that significantly interferes with social &
occupational functioning.
Alzheimer’s disease is also known as senile dementia of the Alzheimer type (SDAT)
or simply Alzheimer’s, the most common form of dementia. It is an incurable, degenerative,
terminal disease.
AD results from an increase in the production or accumulation of specific protein
(β-amyloid protein) in the brain that leads to nerve cell death.
EPIDEMIOLOGY:
?According to 2015 report, AD affects 5.3 million people in US.
?AD was the 6th leading cause of death in 2015.
?AD and other dementias are more likely common in African Americans, than in whites.
?According to the WHO’s review in 2000, on the “global burden of dementia”:
approximate rates of dementia are under 1% in persons aged 60-69 years and 39%
in persons aged 90-95 years, prevalence doubles with every 5 years of age (within
the above ranges).
ETIOLOGY:
The exact etiology of Alzheimer’s disease is not known and associated with risk factors.
But stated that there are several genetical and environmental factors have been explored as
potential causes of the Alzheimer’s disease.
Other factors include:
1. Advancing age
2. Family history
3. Trauma
4. Education
5. Vascular disease like stroke etc.
RISK FACTORS:
The common risk factors
for developing Alzheimer’s
disease are:
?Increased age (over 65 years of age)
?Hypertension (high blood pressure)
?Increased cholesterol levels
?Coronary artery disease
?Diabetes
Other risk factors are:
?Genetics
?Smoking and alcohol use
?Plasma homocysteine
?Down syndrome
?Mild cognitive impairment
PATHOPHYSIOLOGY:
The brain has billions of neurons, each with an axon and many dendrites. To stay
healthy, neurons must communicate with each other, carry out metabolism and repair
themselves. AD disrupts all three of these essential jobs.
There are two signature lesions in Alzheimer’s disease. They are:
1. Neuritic plaques/ β-amyloid plaques, which are dense deposits of protein and cellular
material that accumulate outside and around nerve cells.
2. Neurofibrillary tangles (NFT’s), which are twisted fibers that build up inside the nerve
cell.
1. NEURITIC PLAQUES:
Deposits of a protein fragment called β-amyloid, that accumulates in the spaces between
the nerve cells (neurons).
APP (amyloid precursor protein) is the precursor of amyloid plaque.
a) APP sticks through the neuron membrane.
b) Enzymes like β-secretase and α-secretase cut the APP into fragments of protein
(neurotoxic Aβ42 fragment), including β-amyloid.
c) β-amyloid fragments come together in clumps to form plaques.
In AD, many of these clumps form, disrupting the work of neurons. This affects the
hippocampus and other areas of the cerebral cortex.
APP (amyloid precursor protein)
Cleaved by β-secretase and α-secretase
Mutation of amyloid precursor protein on chromosome no. 21
Increased production of amyloid precursor protein
Produces of amyloid protein
Accumulation of β-amyloid protein
(due to increased production of APP)
Directly neurotoxin
Alzheimer’s disease
2. NEUROFIBRILLARY TANGLES
(NFT’S):
Neurons have an internal support structure
partly made up of microtubules. A protein called
“tau” helps to stabilize microtubules. In AD, “tau”
changes, causing microtubules to collapse and
“tau” proteins clump together to form
neurofibrillary tangles.
CONTD
… Although autopsy studies show that most people develop
some plaques & tangles as they age
Those with AD tend to develop them far more & in a predictable pattern
They develop in the areas important for memory
before spreading to other regions
Plaques & tangles disable/block communication among neurons
Gradually spread to other areas of brain
Causes symptoms of Alzheimer’s disease
SYMPTOMS:
The symptoms of AD are classified as:
1. Cognitive symptoms
2. Non cognitive symptoms
3. Functional symptoms
CONTD…
1. Cognitive symptoms:
? Memory loss (poor recall
and losing items)
? Aphasia (circumlocution and anomia)
? Apraxia, agnosia,
? Disorientation (impaired perception of
time and unable to recognize familiar
people)
? Impaired executive function.
2. Non cognitive symptoms:
? Depression, psychotic
(hallucination and delusions).
symptoms
? Behavioural disturbances (physical and
verbal aggression, motor hyperactivity,
uncooperativeness, wandering, repetitive
mannerisms and activities and
combativeness).
3. Functional symptoms:
? Inability to care for self (dressing, bathing,
eating etc.)
PHARMACOLOGICAL TREATMENT:
1. Cholinesterase inhibitors:
MOA:
These drugs selectively inhibit acetyl cholinesterase, the enzyme responsible for the
destruction of acetyl choline. Thus, acetyl choline gets accumulated (improves Ach
availability) and produces cholinergic effects.
Acetyl CoA + Choline
Choline acetyl transferase
Acetyl choline (Ach)
Acetyl cholinesterase
Choline + Acetate
Cholinesterase inhibitors
(e.g. donepezil, rivastigmine, galantamine)
CONTD…
2. NMDA receptor antagonists (Memantine):
MOA:
The N-methyl-D-aspartate receptor (also known as NMDA receptor) is a glutamate
receptor and ion channel protein found in nerve cells. The NMDA receptor is very
important in controlling synaptic plasticity and memory function. NMDA type
glutamate receptors may be over activated in AD (glutamatergic excitotoxicity).
Memantine binds preferentially to NMDA receptor and blocks it. Blocking usually occurs
only under conditions of excessive stimulation and not under neurotransmission.
CONTD
… Memantine
Blocks
NMDA receptor (blocks glutamate)
Prevents too much calcium from moving into the brain cells
Reduces excessive stimulation
Reduces the symptoms of Alzheimer’s disease
? ADRs: Hypertension, cataract, CVA, thromboembolism etc.
? Uses: It is commonly used for moderate-severe dementia in patients with AD.
? Dose: Memantine: 5mg OD (initial dose); 20mg/day (Max. dose)
hbs ppt.pdfgjzgkxhkhkluyktdkgkhdulfttdlhx
Ad

Recommended

Pathophysiology and management of alzheimer's disease
Pathophysiology and management of alzheimer's disease
Soujanya Pharm.D
?
Presentation for Alzheimers Disease.pptx
Presentation for Alzheimers Disease.pptx
ravisutar1
?
Alzheimers Disease
Alzheimers Disease
Sri Ramachandra University
?
Alzheimer's disease
Alzheimer's disease
Dr. Koppala R.V.S. Chaitanya
?
Alzheimers disease by Ritika soni
Alzheimers disease by Ritika soni
Shimla
?
ALZHEIMER'S DEMENTIA anu_11034nhjjjjjjjjkk5.pptx
ALZHEIMER'S DEMENTIA anu_11034nhjjjjjjjjkk5.pptx
ShanuSoni7
?
Alzheimers presentation.docx (1)
Alzheimers presentation.docx (1)
Ashwani Kumar
?
Alzheimers presentation.docx
Alzheimers presentation.docx
teredeloscobos
?
Alzheimers presentation.docx
Alzheimers presentation.docx
Hena Jawaid
?
alzheimersdisease final.pptx
alzheimersdisease final.pptx
Komal Upreti
?
Yoga for Alzheimer's Disease
Yoga for Alzheimer's Disease
Health Education Library for People
?
Alzheimer
Alzheimer
Amira Badr
?
ALZHEIMERS DISEASE.pptx
ALZHEIMERS DISEASE.pptx
punith p
?
Alzheimer's disease.pptx
Alzheimer's disease.pptx
Aman Kumar
?
Alzheimer's disease
Alzheimer's disease
Sanil Varghese
?
Tomser Ali Group No 22 AD.pptxAnxiety-Understanding-and-Managing-It.pptx
Tomser Ali Group No 22 AD.pptxAnxiety-Understanding-and-Managing-It.pptx
neestom1998
?
Alzheimer's disease
Alzheimer's disease
SwalihaK
?
Alzheimers disease and its treatments
Alzheimers disease and its treatments
Ravish Yadav
?
Overview of Alzheimer's disease
Overview of Alzheimer's disease
VIJAYRAJA DHANRAJ
?
Alzheimer's disease.pptx
Alzheimer's disease.pptx
ChirayuRegmi2
?
Alzheimer's Disease and its pathophysiology
Alzheimer's Disease and its pathophysiology
Achyut Adhikari
?
Alzheimer disease
Alzheimer disease
Dr. Ramesh Bhandari
?
Clin Neuro Dementia Alz Lec.
Clin Neuro Dementia Alz Lec.
Shaikhani.
?
Alzheimer'S Diseases
Alzheimer'S Diseases
AlmasMajeeth
?
Alzheimer's disease
Alzheimer's disease
Muhammad Ahsan
?
LECTURE 8- Dementia DR SHAHB- DR AMAL.pptx
LECTURE 8- Dementia DR SHAHB- DR AMAL.pptx
Rnoun
?
Neurodegenerative diseases
Neurodegenerative diseases
Fabio Grubba
?
A disease of dementia general medicine .pptx
A disease of dementia general medicine .pptx
rhyh6d84h7
?
527751381-Parkinson-Disease-狠狠撸s (1).pdf
527751381-Parkinson-Disease-狠狠撸s (1).pdf
SKGAMING32
?
merged.pdfcvvbbbbbbbbbbbbbhhhbbbbbbbbbiydydd
merged.pdfcvvbbbbbbbbbbbbbhhhbbbbbbbbbiydydd
SKGAMING32
?

More Related Content

Similar to hbs ppt.pdfgjzgkxhkhkluyktdkgkhdulfttdlhx (20)

Alzheimers presentation.docx
Alzheimers presentation.docx
Hena Jawaid
?
alzheimersdisease final.pptx
alzheimersdisease final.pptx
Komal Upreti
?
Yoga for Alzheimer's Disease
Yoga for Alzheimer's Disease
Health Education Library for People
?
Alzheimer
Alzheimer
Amira Badr
?
ALZHEIMERS DISEASE.pptx
ALZHEIMERS DISEASE.pptx
punith p
?
Alzheimer's disease.pptx
Alzheimer's disease.pptx
Aman Kumar
?
Alzheimer's disease
Alzheimer's disease
Sanil Varghese
?
Tomser Ali Group No 22 AD.pptxAnxiety-Understanding-and-Managing-It.pptx
Tomser Ali Group No 22 AD.pptxAnxiety-Understanding-and-Managing-It.pptx
neestom1998
?
Alzheimer's disease
Alzheimer's disease
SwalihaK
?
Alzheimers disease and its treatments
Alzheimers disease and its treatments
Ravish Yadav
?
Overview of Alzheimer's disease
Overview of Alzheimer's disease
VIJAYRAJA DHANRAJ
?
Alzheimer's disease.pptx
Alzheimer's disease.pptx
ChirayuRegmi2
?
Alzheimer's Disease and its pathophysiology
Alzheimer's Disease and its pathophysiology
Achyut Adhikari
?
Alzheimer disease
Alzheimer disease
Dr. Ramesh Bhandari
?
Clin Neuro Dementia Alz Lec.
Clin Neuro Dementia Alz Lec.
Shaikhani.
?
Alzheimer'S Diseases
Alzheimer'S Diseases
AlmasMajeeth
?
Alzheimer's disease
Alzheimer's disease
Muhammad Ahsan
?
LECTURE 8- Dementia DR SHAHB- DR AMAL.pptx
LECTURE 8- Dementia DR SHAHB- DR AMAL.pptx
Rnoun
?
Neurodegenerative diseases
Neurodegenerative diseases
Fabio Grubba
?
A disease of dementia general medicine .pptx
A disease of dementia general medicine .pptx
rhyh6d84h7
?
Alzheimers presentation.docx
Alzheimers presentation.docx
Hena Jawaid
?
alzheimersdisease final.pptx
alzheimersdisease final.pptx
Komal Upreti
?
ALZHEIMERS DISEASE.pptx
ALZHEIMERS DISEASE.pptx
punith p
?
Alzheimer's disease.pptx
Alzheimer's disease.pptx
Aman Kumar
?
Tomser Ali Group No 22 AD.pptxAnxiety-Understanding-and-Managing-It.pptx
Tomser Ali Group No 22 AD.pptxAnxiety-Understanding-and-Managing-It.pptx
neestom1998
?
Alzheimer's disease
Alzheimer's disease
SwalihaK
?
Alzheimers disease and its treatments
Alzheimers disease and its treatments
Ravish Yadav
?
Overview of Alzheimer's disease
Overview of Alzheimer's disease
VIJAYRAJA DHANRAJ
?
Alzheimer's disease.pptx
Alzheimer's disease.pptx
ChirayuRegmi2
?
Alzheimer's Disease and its pathophysiology
Alzheimer's Disease and its pathophysiology
Achyut Adhikari
?
Clin Neuro Dementia Alz Lec.
Clin Neuro Dementia Alz Lec.
Shaikhani.
?
LECTURE 8- Dementia DR SHAHB- DR AMAL.pptx
LECTURE 8- Dementia DR SHAHB- DR AMAL.pptx
Rnoun
?
Neurodegenerative diseases
Neurodegenerative diseases
Fabio Grubba
?
A disease of dementia general medicine .pptx
A disease of dementia general medicine .pptx
rhyh6d84h7
?

More from SKGAMING32 (10)

527751381-Parkinson-Disease-狠狠撸s (1).pdf
527751381-Parkinson-Disease-狠狠撸s (1).pdf
SKGAMING32
?
merged.pdfcvvbbbbbbbbbbbbbhhhbbbbbbbbbiydydd
merged.pdfcvvbbbbbbbbbbbbbhhhbbbbbbbbbiydydd
SKGAMING32
?
Lecture One.pdfmdndnddndndndndndndndjdjfjfj
Lecture One.pdfmdndnddndndndndndndndjdjfjfj
SKGAMING32
?
Total protein in serum_20241110_145525_0000.pdf
Total protein in serum_20241110_145525_0000.pdf
SKGAMING32
?
a8 BSC BWM (BIOMEDICAL WASTE MANAGEMENT) .pptx
a8 BSC BWM (BIOMEDICAL WASTE MANAGEMENT) .pptx
SKGAMING32
?
Presentation (2) (1).pptxUpload a presentation to download Abnormal morpholog...
Presentation (2) (1).pptxUpload a presentation to download Abnormal morpholog...
SKGAMING32
?
NABL.pdf NABL.pdfNABL.pdfNABL.NABL.pdfwwww
NABL.pdf NABL.pdfNABL.pdfNABL.NABL.pdfwwww
SKGAMING32
?
ftw.pdfThik h mai aa rha hu par presentation nhi dunga
ftw.pdfThik h mai aa rha hu par presentation nhi dunga
SKGAMING32
?
marcqi_blood_transfusion.pdfUNDERSTAND WORD FEATURE
marcqi_blood_transfusion.pdfUNDERSTAND WORD FEATURE
SKGAMING32
?
ftw SURAJ KUMAR.pdf: Better titles and descriptions lead to more readers
ftw SURAJ KUMAR.pdf: Better titles and descriptions lead to more readers
SKGAMING32
?
527751381-Parkinson-Disease-狠狠撸s (1).pdf
527751381-Parkinson-Disease-狠狠撸s (1).pdf
SKGAMING32
?
merged.pdfcvvbbbbbbbbbbbbbhhhbbbbbbbbbiydydd
merged.pdfcvvbbbbbbbbbbbbbhhhbbbbbbbbbiydydd
SKGAMING32
?
Lecture One.pdfmdndnddndndndndndndndjdjfjfj
Lecture One.pdfmdndnddndndndndndndndjdjfjfj
SKGAMING32
?
Total protein in serum_20241110_145525_0000.pdf
Total protein in serum_20241110_145525_0000.pdf
SKGAMING32
?
a8 BSC BWM (BIOMEDICAL WASTE MANAGEMENT) .pptx
a8 BSC BWM (BIOMEDICAL WASTE MANAGEMENT) .pptx
SKGAMING32
?
Presentation (2) (1).pptxUpload a presentation to download Abnormal morpholog...
Presentation (2) (1).pptxUpload a presentation to download Abnormal morpholog...
SKGAMING32
?
NABL.pdf NABL.pdfNABL.pdfNABL.NABL.pdfwwww
NABL.pdf NABL.pdfNABL.pdfNABL.NABL.pdfwwww
SKGAMING32
?
ftw.pdfThik h mai aa rha hu par presentation nhi dunga
ftw.pdfThik h mai aa rha hu par presentation nhi dunga
SKGAMING32
?
marcqi_blood_transfusion.pdfUNDERSTAND WORD FEATURE
marcqi_blood_transfusion.pdfUNDERSTAND WORD FEATURE
SKGAMING32
?
ftw SURAJ KUMAR.pdf: Better titles and descriptions lead to more readers
ftw SURAJ KUMAR.pdf: Better titles and descriptions lead to more readers
SKGAMING32
?
Ad

Recently uploaded (20)

MULTI SENSORY EXPERIENCE DESIGN RESEARCH
MULTI SENSORY EXPERIENCE DESIGN RESEARCH
Samuel Thuo
?
Aimee White Visual Thinking, Graphic Design, Livermore
Aimee White Visual Thinking, Graphic Design, Livermore
aimeewhite13
?
Marketplaces to Buy and Sell Social Media Accounts.pdf
Marketplaces to Buy and Sell Social Media Accounts.pdf
jamedthomsn
?
Formal Informal Apology letter.pptxvvvvv
Formal Informal Apology letter.pptxvvvvv
iqlimajurayeva
?
Sir Norman Foster Philip Jodidio TASCHEN
Sir Norman Foster Philip Jodidio TASCHEN
FernandoMondragon14
?
Presentation3_architectural presentation case studypptx
Presentation3_architectural presentation case studypptx
maheshwarigarvit2006
?
Digital Poster PPT.pptx..............................
Digital Poster PPT.pptx..............................
AhmedAboElSeoud3
?
最新版美国威斯康星大学普拉特维尔分校毕业证(鲍奥笔毕业证书)原版定制
最新版美国威斯康星大学普拉特维尔分校毕业证(鲍奥笔毕业证书)原版定制
taqyea
?
Exploring the Diverse Types of Textual Aids
Exploring the Diverse Types of Textual Aids
jenicahmendoza1
?
Transformative Storytelling_ Insights from the Sankofa Writing Intensive.pdf
Transformative Storytelling_ Insights from the Sankofa Writing Intensive.pdf
Dr. Rema
?
Simone Laubscher ABC: Redefining Sustainable Luxury in the UAE Fashion Scene
Simone Laubscher ABC: Redefining Sustainable Luxury in the UAE Fashion Scene
Simone Laubscher ABC
?
ART & FUNDAMENTALS OF DESIGN CHAPTER -01.pptx
ART & FUNDAMENTALS OF DESIGN CHAPTER -01.pptx
riteshsahdev2
?
Quectel M10 AT commands Arduino Microcontroller
Quectel M10 AT commands Arduino Microcontroller
AdamSunusiHaruna1
?
Computer Aided Design Introduction Lecture
Computer Aided Design Introduction Lecture
ShavinGopee2
?
Numbers 1 to 100 Circle Flashcard s.pptx
Numbers 1 to 100 Circle Flashcard s.pptx
KarenGimena1
?
最新版西班牙拉蒙鲁尔大学毕业证(鲍搁尝毕业证书)原版定制
最新版西班牙拉蒙鲁尔大学毕业证(鲍搁尝毕业证书)原版定制
Taqyea
?
The_Geometry_of_Natshshshshshsbsure.pptx
The_Geometry_of_Natshshshshshsbsure.pptx
sambal5
?
AI-Driven-Personalization-in-UX-Designing-for-One-in-a-Million.pdf
AI-Driven-Personalization-in-UX-Designing-for-One-in-a-Million.pdf
Sultan Shalakhti
?
The_Sciencehggshshs_of_Everyday_Luck.pptx
The_Sciencehggshshs_of_Everyday_Luck.pptx
zyx10283746
?
AUTOMATIC NUMBER PLATE RECOGNITION 1.pptx
AUTOMATIC NUMBER PLATE RECOGNITION 1.pptx
ABHISHEKCHAKRABORTY931369
?
MULTI SENSORY EXPERIENCE DESIGN RESEARCH
MULTI SENSORY EXPERIENCE DESIGN RESEARCH
Samuel Thuo
?
Aimee White Visual Thinking, Graphic Design, Livermore
Aimee White Visual Thinking, Graphic Design, Livermore
aimeewhite13
?
Marketplaces to Buy and Sell Social Media Accounts.pdf
Marketplaces to Buy and Sell Social Media Accounts.pdf
jamedthomsn
?
Formal Informal Apology letter.pptxvvvvv
Formal Informal Apology letter.pptxvvvvv
iqlimajurayeva
?
Sir Norman Foster Philip Jodidio TASCHEN
Sir Norman Foster Philip Jodidio TASCHEN
FernandoMondragon14
?
Presentation3_architectural presentation case studypptx
Presentation3_architectural presentation case studypptx
maheshwarigarvit2006
?
Digital Poster PPT.pptx..............................
Digital Poster PPT.pptx..............................
AhmedAboElSeoud3
?
最新版美国威斯康星大学普拉特维尔分校毕业证(鲍奥笔毕业证书)原版定制
最新版美国威斯康星大学普拉特维尔分校毕业证(鲍奥笔毕业证书)原版定制
taqyea
?
Exploring the Diverse Types of Textual Aids
Exploring the Diverse Types of Textual Aids
jenicahmendoza1
?
Transformative Storytelling_ Insights from the Sankofa Writing Intensive.pdf
Transformative Storytelling_ Insights from the Sankofa Writing Intensive.pdf
Dr. Rema
?
Simone Laubscher ABC: Redefining Sustainable Luxury in the UAE Fashion Scene
Simone Laubscher ABC: Redefining Sustainable Luxury in the UAE Fashion Scene
Simone Laubscher ABC
?
ART & FUNDAMENTALS OF DESIGN CHAPTER -01.pptx
ART & FUNDAMENTALS OF DESIGN CHAPTER -01.pptx
riteshsahdev2
?
Quectel M10 AT commands Arduino Microcontroller
Quectel M10 AT commands Arduino Microcontroller
AdamSunusiHaruna1
?
Computer Aided Design Introduction Lecture
Computer Aided Design Introduction Lecture
ShavinGopee2
?
Numbers 1 to 100 Circle Flashcard s.pptx
Numbers 1 to 100 Circle Flashcard s.pptx
KarenGimena1
?
最新版西班牙拉蒙鲁尔大学毕业证(鲍搁尝毕业证书)原版定制
最新版西班牙拉蒙鲁尔大学毕业证(鲍搁尝毕业证书)原版定制
Taqyea
?
The_Geometry_of_Natshshshshshsbsure.pptx
The_Geometry_of_Natshshshshshsbsure.pptx
sambal5
?
AI-Driven-Personalization-in-UX-Designing-for-One-in-a-Million.pdf
AI-Driven-Personalization-in-UX-Designing-for-One-in-a-Million.pdf
Sultan Shalakhti
?
The_Sciencehggshshs_of_Everyday_Luck.pptx
The_Sciencehggshshs_of_Everyday_Luck.pptx
zyx10283746
?
Ad

hbs ppt.pdfgjzgkxhkhkluyktdkgkhdulfttdlhx

  • 2. DEFINITION: Alzheimer’s disease (AD) is a neurodegenerative disorder, characterized by cognitive & behavioural impairment that significantly interferes with social & occupational functioning. Alzheimer’s disease is also known as senile dementia of the Alzheimer type (SDAT) or simply Alzheimer’s, the most common form of dementia. It is an incurable, degenerative, terminal disease. AD results from an increase in the production or accumulation of specific protein (β-amyloid protein) in the brain that leads to nerve cell death.
  • 3. EPIDEMIOLOGY: ?According to 2015 report, AD affects 5.3 million people in US. ?AD was the 6th leading cause of death in 2015. ?AD and other dementias are more likely common in African Americans, than in whites. ?According to the WHO’s review in 2000, on the “global burden of dementia”: approximate rates of dementia are under 1% in persons aged 60-69 years and 39% in persons aged 90-95 years, prevalence doubles with every 5 years of age (within the above ranges).
  • 4. ETIOLOGY: The exact etiology of Alzheimer’s disease is not known and associated with risk factors. But stated that there are several genetical and environmental factors have been explored as potential causes of the Alzheimer’s disease. Other factors include: 1. Advancing age 2. Family history 3. Trauma 4. Education 5. Vascular disease like stroke etc.
  • 5. RISK FACTORS: The common risk factors for developing Alzheimer’s disease are: ?Increased age (over 65 years of age) ?Hypertension (high blood pressure) ?Increased cholesterol levels ?Coronary artery disease ?Diabetes Other risk factors are: ?Genetics ?Smoking and alcohol use ?Plasma homocysteine ?Down syndrome ?Mild cognitive impairment
  • 6. PATHOPHYSIOLOGY: The brain has billions of neurons, each with an axon and many dendrites. To stay healthy, neurons must communicate with each other, carry out metabolism and repair themselves. AD disrupts all three of these essential jobs. There are two signature lesions in Alzheimer’s disease. They are: 1. Neuritic plaques/ β-amyloid plaques, which are dense deposits of protein and cellular material that accumulate outside and around nerve cells. 2. Neurofibrillary tangles (NFT’s), which are twisted fibers that build up inside the nerve cell.
  • 7. 1. NEURITIC PLAQUES: Deposits of a protein fragment called β-amyloid, that accumulates in the spaces between the nerve cells (neurons). APP (amyloid precursor protein) is the precursor of amyloid plaque. a) APP sticks through the neuron membrane. b) Enzymes like β-secretase and α-secretase cut the APP into fragments of protein (neurotoxic Aβ42 fragment), including β-amyloid. c) β-amyloid fragments come together in clumps to form plaques. In AD, many of these clumps form, disrupting the work of neurons. This affects the hippocampus and other areas of the cerebral cortex.
  • 8. APP (amyloid precursor protein) Cleaved by β-secretase and α-secretase Mutation of amyloid precursor protein on chromosome no. 21 Increased production of amyloid precursor protein Produces of amyloid protein Accumulation of β-amyloid protein (due to increased production of APP) Directly neurotoxin Alzheimer’s disease
  • 9. 2. NEUROFIBRILLARY TANGLES (NFT’S): Neurons have an internal support structure partly made up of microtubules. A protein called “tau” helps to stabilize microtubules. In AD, “tau” changes, causing microtubules to collapse and “tau” proteins clump together to form neurofibrillary tangles.
  • 10. CONTD … Although autopsy studies show that most people develop some plaques & tangles as they age Those with AD tend to develop them far more & in a predictable pattern They develop in the areas important for memory before spreading to other regions Plaques & tangles disable/block communication among neurons Gradually spread to other areas of brain Causes symptoms of Alzheimer’s disease
  • 11. SYMPTOMS: The symptoms of AD are classified as: 1. Cognitive symptoms 2. Non cognitive symptoms 3. Functional symptoms
  • 12. CONTD… 1. Cognitive symptoms: ? Memory loss (poor recall and losing items) ? Aphasia (circumlocution and anomia) ? Apraxia, agnosia, ? Disorientation (impaired perception of time and unable to recognize familiar people) ? Impaired executive function. 2. Non cognitive symptoms: ? Depression, psychotic (hallucination and delusions). symptoms ? Behavioural disturbances (physical and verbal aggression, motor hyperactivity, uncooperativeness, wandering, repetitive mannerisms and activities and combativeness). 3. Functional symptoms: ? Inability to care for self (dressing, bathing, eating etc.)
  • 13. PHARMACOLOGICAL TREATMENT: 1. Cholinesterase inhibitors: MOA: These drugs selectively inhibit acetyl cholinesterase, the enzyme responsible for the destruction of acetyl choline. Thus, acetyl choline gets accumulated (improves Ach availability) and produces cholinergic effects. Acetyl CoA + Choline Choline acetyl transferase Acetyl choline (Ach) Acetyl cholinesterase Choline + Acetate Cholinesterase inhibitors (e.g. donepezil, rivastigmine, galantamine)
  • 14. CONTD… 2. NMDA receptor antagonists (Memantine): MOA: The N-methyl-D-aspartate receptor (also known as NMDA receptor) is a glutamate receptor and ion channel protein found in nerve cells. The NMDA receptor is very important in controlling synaptic plasticity and memory function. NMDA type glutamate receptors may be over activated in AD (glutamatergic excitotoxicity). Memantine binds preferentially to NMDA receptor and blocks it. Blocking usually occurs only under conditions of excessive stimulation and not under neurotransmission.
  • 15. CONTD … Memantine Blocks NMDA receptor (blocks glutamate) Prevents too much calcium from moving into the brain cells Reduces excessive stimulation Reduces the symptoms of Alzheimer’s disease ? ADRs: Hypertension, cataract, CVA, thromboembolism etc. ? Uses: It is commonly used for moderate-severe dementia in patients with AD. ? Dose: Memantine: 5mg OD (initial dose); 20mg/day (Max. dose)